 | • レポートコード：MRC2-11QY13305 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はウィルムス腫瘍治療のグローバル市場について調査・分析したレポートです。種類別（カボザンチニブ、SEL-12034、ラコツモマブ、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ウィルムス腫瘍治療の競争状況、市場シェア ・世界のウィルムス腫瘍治療市場：種類別市場規模 2015年-2020年（カボザンチニブ、SEL-12034、ラコツモマブ、その他） ・世界のウィルムス腫瘍治療市場：種類別市場規模予測 2021年-2026年（カボザンチニブ、SEL-12034、ラコツモマブ、その他） ・世界のウィルムス腫瘍治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のウィルムス腫瘍治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のウィルムス腫瘍治療市場分析：米国、カナダ ・ヨーロッパのウィルムス腫瘍治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのウィルムス腫瘍治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のウィルムス腫瘍治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのウィルムス腫瘍治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Exelixis Inc、NanoSmart Pharmaceuticals Inc、Recombio SL、Selvita SA ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Wilms’ Tumor Treatment Market
The global Wilms’ Tumor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Wilms’ Tumor Treatment Scope and Market Size
Wilms’ Tumor Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Wilms’ Tumor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Wilms’ Tumor Treatment market is segmented into
Cabozantinib s
SEL-12034
Racotumomab
Others
Segment by Application, the Wilms’ Tumor Treatment market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Wilms’ Tumor Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Wilms’ Tumor Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Wilms’ Tumor Treatment Market Share Analysis
Wilms’ Tumor Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Wilms’ Tumor Treatment business, the date to enter into the Wilms’ Tumor Treatment market, Wilms’ Tumor Treatment product introduction, recent developments, etc.
The major vendors covered:
Exelixis Inc
NanoSmart Pharmaceuticals Inc
Recombio SL
Selvita SA
…
1 Study Coverage
1.1 Wilms’ Tumor Treatment Product Introduction
1.2 Market Segments
1.3 Key Wilms’ Tumor Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Wilms’ Tumor Treatment Market Size Growth Rate by Type
1.4.2 Cabozantinib s
1.4.3 SEL-12034
1.4.4 Racotumomab
1.4.5 Others
1.5 Market by Application
1.5.1 Global Wilms’ Tumor Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Wilms’ Tumor Treatment Market Size, Estimates and Forecasts
2.1.1 Global Wilms’ Tumor Treatment Revenue 2015-2026
2.1.2 Global Wilms’ Tumor Treatment Sales 2015-2026
2.2 Global Wilms’ Tumor Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Wilms’ Tumor Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Wilms’ Tumor Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Wilms’ Tumor Treatment Competitor Landscape by Players
3.1 Wilms’ Tumor Treatment Sales by Manufacturers
3.1.1 Wilms’ Tumor Treatment Sales by Manufacturers (2015-2020)
3.1.2 Wilms’ Tumor Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Wilms’ Tumor Treatment Revenue by Manufacturers
3.2.1 Wilms’ Tumor Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Wilms’ Tumor Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Wilms’ Tumor Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Wilms’ Tumor Treatment Revenue in 2019
3.2.5 Global Wilms’ Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Wilms’ Tumor Treatment Price by Manufacturers
3.4 Wilms’ Tumor Treatment Manufacturing Base Distribution, Product Types
3.4.1 Wilms’ Tumor Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Wilms’ Tumor Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Wilms’ Tumor Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Wilms’ Tumor Treatment Market Size by Type (2015-2020)
4.1.1 Global Wilms’ Tumor Treatment Sales by Type (2015-2020)
4.1.2 Global Wilms’ Tumor Treatment Revenue by Type (2015-2020)
4.1.3 Wilms’ Tumor Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Wilms’ Tumor Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Wilms’ Tumor Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Wilms’ Tumor Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Wilms’ Tumor Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Wilms’ Tumor Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Wilms’ Tumor Treatment Market Size by Application (2015-2020)
5.1.1 Global Wilms’ Tumor Treatment Sales by Application (2015-2020)
5.1.2 Global Wilms’ Tumor Treatment Revenue by Application (2015-2020)
5.1.3 Wilms’ Tumor Treatment Price by Application (2015-2020)
5.2 Wilms’ Tumor Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Wilms’ Tumor Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Wilms’ Tumor Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Wilms’ Tumor Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Wilms’ Tumor Treatment by Country
6.1.1 North America Wilms’ Tumor Treatment Sales by Country
6.1.2 North America Wilms’ Tumor Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Wilms’ Tumor Treatment Market Facts & Figures by Type
6.3 North America Wilms’ Tumor Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Wilms’ Tumor Treatment by Country
7.1.1 Europe Wilms’ Tumor Treatment Sales by Country
7.1.2 Europe Wilms’ Tumor Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Wilms’ Tumor Treatment Market Facts & Figures by Type
7.3 Europe Wilms’ Tumor Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Wilms’ Tumor Treatment by Region
8.1.1 Asia Pacific Wilms’ Tumor Treatment Sales by Region
8.1.2 Asia Pacific Wilms’ Tumor Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Wilms’ Tumor Treatment Market Facts & Figures by Type
8.3 Asia Pacific Wilms’ Tumor Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Wilms’ Tumor Treatment by Country
9.1.1 Latin America Wilms’ Tumor Treatment Sales by Country
9.1.2 Latin America Wilms’ Tumor Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Wilms’ Tumor Treatment Market Facts & Figures by Type
9.3 Central & South America Wilms’ Tumor Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Wilms’ Tumor Treatment by Country
10.1.1 Middle East and Africa Wilms’ Tumor Treatment Sales by Country
10.1.2 Middle East and Africa Wilms’ Tumor Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Wilms’ Tumor Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Wilms’ Tumor Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Exelixis Inc
11.1.1 Exelixis Inc Corporation Information
11.1.2 Exelixis Inc Description and Business Overview
11.1.3 Exelixis Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Exelixis Inc Wilms’ Tumor Treatment Products Offered
11.1.5 Exelixis Inc Related Developments
11.2 NanoSmart Pharmaceuticals Inc
11.2.1 NanoSmart Pharmaceuticals Inc Corporation Information
11.2.2 NanoSmart Pharmaceuticals Inc Description and Business Overview
11.2.3 NanoSmart Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 NanoSmart Pharmaceuticals Inc Wilms’ Tumor Treatment Products Offered
11.2.5 NanoSmart Pharmaceuticals Inc Related Developments
11.3 Recombio SL
11.3.1 Recombio SL Corporation Information
11.3.2 Recombio SL Description and Business Overview
11.3.3 Recombio SL Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Recombio SL Wilms’ Tumor Treatment Products Offered
11.3.5 Recombio SL Related Developments
11.4 Selvita SA
11.4.1 Selvita SA Corporation Information
11.4.2 Selvita SA Description and Business Overview
11.4.3 Selvita SA Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Selvita SA Wilms’ Tumor Treatment Products Offered
11.4.5 Selvita SA Related Developments
11.1 Exelixis Inc
11.1.1 Exelixis Inc Corporation Information
11.1.2 Exelixis Inc Description and Business Overview
11.1.3 Exelixis Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Exelixis Inc Wilms’ Tumor Treatment Products Offered
11.1.5 Exelixis Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Wilms’ Tumor Treatment Market Estimates and Projections by Region
12.1.1 Global Wilms’ Tumor Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Wilms’ Tumor Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Wilms’ Tumor Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Wilms’ Tumor Treatment Sales Forecast (2021-2026)
12.2.2 North America: Wilms’ Tumor Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Wilms’ Tumor Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Wilms’ Tumor Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Wilms’ Tumor Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Wilms’ Tumor Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Wilms’ Tumor Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Wilms’ Tumor Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Wilms’ Tumor Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Wilms’ Tumor Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Wilms’ Tumor Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Wilms’ Tumor Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Wilms’ Tumor Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Wilms’ Tumor Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Wilms’ Tumor Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Wilms’ Tumor Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Wilms’ Tumor Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Wilms’ Tumor Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Wilms’ Tumor Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Wilms’ Tumor Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Wilms’ Tumor Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Wilms' Tumor Treatment Market Segments
Table 2. Ranking of Global Top Wilms' Tumor Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Wilms' Tumor Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Cabozantinib s
Table 5. Major Manufacturers of SEL-12034
Table 6. Major Manufacturers of Racotumomab
Table 7. Major Manufacturers of Others
Table 8. Global Wilms' Tumor Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Wilms' Tumor Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Wilms' Tumor Treatment Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Wilms' Tumor Treatment Sales Market Share by Regions (2015-2020)
Table 12. Global Wilms' Tumor Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Wilms' Tumor Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Wilms' Tumor Treatment Sales Share by Manufacturers (2015-2020)
Table 15. Global Wilms' Tumor Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Wilms' Tumor Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wilms' Tumor Treatment as of 2019)
Table 17. Wilms' Tumor Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Wilms' Tumor Treatment Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Wilms' Tumor Treatment Price (2015-2020) (USD/Pcs)
Table 20. Wilms' Tumor Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Wilms' Tumor Treatment Product Type
Table 22. Date of International Manufacturers Enter into Wilms' Tumor Treatment Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Wilms' Tumor Treatment Sales by Type (2015-2020) (K Pcs)
Table 25. Global Wilms' Tumor Treatment Sales Share by Type (2015-2020)
Table 26. Global Wilms' Tumor Treatment Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Wilms' Tumor Treatment Revenue Share by Type (2015-2020)
Table 28. Wilms' Tumor Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Wilms' Tumor Treatment Sales by Application (2015-2020) (K Pcs)
Table 30. Global Wilms' Tumor Treatment Sales Share by Application (2015-2020)
Table 31. North America Wilms' Tumor Treatment Sales by Country (2015-2020) (K Pcs)
Table 32. North America Wilms' Tumor Treatment Sales Market Share by Country (2015-2020)
Table 33. North America Wilms' Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Wilms' Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 35. North America Wilms' Tumor Treatment Sales by Type (2015-2020) (K Pcs)
Table 36. North America Wilms' Tumor Treatment Sales Market Share by Type (2015-2020)
Table 37. North America Wilms' Tumor Treatment Sales by Application (2015-2020) (K Pcs)
Table 38. North America Wilms' Tumor Treatment Sales Market Share by Application (2015-2020)
Table 39. Europe Wilms' Tumor Treatment Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Wilms' Tumor Treatment Sales Market Share by Country (2015-2020)
Table 41. Europe Wilms' Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Wilms' Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 43. Europe Wilms' Tumor Treatment Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Wilms' Tumor Treatment Sales Market Share by Type (2015-2020)
Table 45. Europe Wilms' Tumor Treatment Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Wilms' Tumor Treatment Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Wilms' Tumor Treatment Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Wilms' Tumor Treatment Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Wilms' Tumor Treatment Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Wilms' Tumor Treatment Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Wilms' Tumor Treatment Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Wilms' Tumor Treatment Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Wilms' Tumor Treatment Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Wilms' Tumor Treatment Sales Market Share by Application (2015-2020)
Table 55. Latin America Wilms' Tumor Treatment Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Wilms' Tumor Treatment Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Wilms' Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Wilms' Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 59. Latin America Wilms' Tumor Treatment Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Wilms' Tumor Treatment Sales Market Share by Type (2015-2020)
Table 61. Latin America Wilms' Tumor Treatment Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Wilms' Tumor Treatment Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Wilms' Tumor Treatment Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Wilms' Tumor Treatment Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Wilms' Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Wilms' Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Wilms' Tumor Treatment Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Wilms' Tumor Treatment Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Wilms' Tumor Treatment Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Wilms' Tumor Treatment Sales Market Share by Application (2015-2020)
Table 71. Exelixis Inc Corporation Information
Table 72. Exelixis Inc Description and Major Businesses
Table 73. Exelixis Inc Wilms' Tumor Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Exelixis Inc Product
Table 75. Exelixis Inc Recent Development
Table 76. NanoSmart Pharmaceuticals Inc Corporation Information
Table 77. NanoSmart Pharmaceuticals Inc Description and Major Businesses
Table 78. NanoSmart Pharmaceuticals Inc Wilms' Tumor Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. NanoSmart Pharmaceuticals Inc Product
Table 80. NanoSmart Pharmaceuticals Inc Recent Development
Table 81. Recombio SL Corporation Information
Table 82. Recombio SL Description and Major Businesses
Table 83. Recombio SL Wilms' Tumor Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Recombio SL Product
Table 85. Recombio SL Recent Development
Table 86. Selvita SA Corporation Information
Table 87. Selvita SA Description and Major Businesses
Table 88. Selvita SA Wilms' Tumor Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Selvita SA Product
Table 90. Selvita SA Recent Development
Table 91. Global Wilms' Tumor Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 92. Global Wilms' Tumor Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 93. Global Wilms' Tumor Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 94. Global Wilms' Tumor Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 95. North America: Wilms' Tumor Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 96. North America: Wilms' Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Europe: Wilms' Tumor Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. Europe: Wilms' Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Asia Pacific: Wilms' Tumor Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 100. Asia Pacific: Wilms' Tumor Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 101. Latin America: Wilms' Tumor Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. Latin America: Wilms' Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Middle East and Africa: Wilms' Tumor Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Middle East and Africa: Wilms' Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 106. Key Challenges
Table 107. Market Risks
Table 108. Main Points Interviewed from Key Wilms' Tumor Treatment Players
Table 109. Wilms' Tumor Treatment Customers List
Table 110. Wilms' Tumor Treatment Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Wilms' Tumor Treatment Product Picture
Figure 2. Global Wilms' Tumor Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Cabozantinib s Product Picture
Figure 4. SEL-12034 Product Picture
Figure 5. Racotumomab Product Picture
Figure 6. Others Product Picture
Figure 7. Global Wilms' Tumor Treatment Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Wilms' Tumor Treatment Report Years Considered
Figure 12. Global Wilms' Tumor Treatment Market Size 2015-2026 (US$ Million)
Figure 13. Global Wilms' Tumor Treatment Sales 2015-2026 (K Pcs)
Figure 14. Global Wilms' Tumor Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Wilms' Tumor Treatment Sales Market Share by Region (2015-2020)
Figure 16. Global Wilms' Tumor Treatment Sales Market Share by Region in 2019
Figure 17. Global Wilms' Tumor Treatment Revenue Market Share by Region (2015-2020)
Figure 18. Global Wilms' Tumor Treatment Revenue Market Share by Region in 2019
Figure 19. Global Wilms' Tumor Treatment Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Wilms' Tumor Treatment Revenue in 2019
Figure 21. Wilms' Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Wilms' Tumor Treatment Sales Market Share by Type (2015-2020)
Figure 23. Global Wilms' Tumor Treatment Sales Market Share by Type in 2019
Figure 24. Global Wilms' Tumor Treatment Revenue Market Share by Type (2015-2020)
Figure 25. Global Wilms' Tumor Treatment Revenue Market Share by Type in 2019
Figure 26. Global Wilms' Tumor Treatment Market Share by Price Range (2015-2020)
Figure 27. Global Wilms' Tumor Treatment Sales Market Share by Application (2015-2020)
Figure 28. Global Wilms' Tumor Treatment Sales Market Share by Application in 2019
Figure 29. Global Wilms' Tumor Treatment Revenue Market Share by Application (2015-2020)
Figure 30. Global Wilms' Tumor Treatment Revenue Market Share by Application in 2019
Figure 31. North America Wilms' Tumor Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Wilms' Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Wilms' Tumor Treatment Sales Market Share by Country in 2019
Figure 34. North America Wilms' Tumor Treatment Revenue Market Share by Country in 2019
Figure 35. U.S. Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Wilms' Tumor Treatment Market Share by Type in 2019
Figure 40. North America Wilms' Tumor Treatment Market Share by Application in 2019
Figure 41. Europe Wilms' Tumor Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Wilms' Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Wilms' Tumor Treatment Sales Market Share by Country in 2019
Figure 44. Europe Wilms' Tumor Treatment Revenue Market Share by Country in 2019
Figure 45. Germany Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Wilms' Tumor Treatment Market Share by Type in 2019
Figure 56. Europe Wilms' Tumor Treatment Market Share by Application in 2019
Figure 57. Asia Pacific Wilms' Tumor Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Wilms' Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Wilms' Tumor Treatment Sales Market Share by Region in 2019
Figure 60. Asia Pacific Wilms' Tumor Treatment Revenue Market Share by Region in 2019
Figure 61. China Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Wilms' Tumor Treatment Market Share by Type in 2019
Figure 84. Asia Pacific Wilms' Tumor Treatment Market Share by Application in 2019
Figure 85. Latin America Wilms' Tumor Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Wilms' Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Wilms' Tumor Treatment Sales Market Share by Country in 2019
Figure 88. Latin America Wilms' Tumor Treatment Revenue Market Share by Country in 2019
Figure 89. Mexico Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Wilms' Tumor Treatment Market Share by Type in 2019
Figure 96. Latin America Wilms' Tumor Treatment Market Share by Application in 2019
Figure 97. Middle East and Africa Wilms' Tumor Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Wilms' Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Wilms' Tumor Treatment Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Wilms' Tumor Treatment Revenue Market Share by Country in 2019
Figure 101. Turkey Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Wilms' Tumor Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Wilms' Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Wilms' Tumor Treatment Market Share by Type in 2019
Figure 108. Middle East and Africa Wilms' Tumor Treatment Market Share by Application in 2019
Figure 109. North America Wilms' Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Wilms' Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Wilms' Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Wilms' Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Wilms' Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Wilms' Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Wilms' Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Wilms' Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Wilms' Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Wilms' Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
ウィルムス腫瘍タンパク質の世界市場（～2026年） Market Analysis and Insights: Global Wilms Tumor Protein Market The global Wilms Tumor Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Wilms Tumor Protein Scope and Market Size Wilms Tumor Protein market is seg…- 交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…
- 性腺性腺間質腫瘍治療の世界市場（～2026年） The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Market Analysis and Insights: Global Sex Cord Gonadal Stromal Tumor Treatment Market The global Sex Cord Gonadal Strom…
- 脳腫瘍治療の世界市場（～2026年） Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient's age and general health. Various treatments for curing brain tumor are surgery, radiation therapy, and chemotherapy, immunotherapy and so on which reduce the symptoms …
- 消化管間質腫瘍（GIST）の世界市場（～2026年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…